» Articles » PMID: 2408147

Inhibition of Serum- and Ras-stimulated DNA Synthesis by Antibodies to Phospholipase C

Overview
Journal Science
Specialty Science
Date 1990 Mar 2
PMID 2408147
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Several immunologically distinct isozymes of inositol phospholipid-specific phospholipase C (PLC) have been purified from bovine brain. Murine NIH 3T3 fibroblasts were found to express PLC-gamma, but the expression of PLC-beta was barely detectable by radioimmunoassay or protein immunoblot. A mixture of monoclonal antibodies was identified that neutralizes the biological activity of both endogenous and injected purified PLC-gamma. When co-injected with oncogenic Ras protein or PLC-gamma, this mixture of antibodies inhibited the induction of DNA synthesis that characteristically results from the injection of these proteins into quiescent 3T3 cells. However, when oncogenic Ras protein or PLC-gamma was co-injected with a neutralizing monoclonal antibody to Ras, only the DNA synthesis induced by the Ras protein was inhibited--that induced by PLC was unaffected. These results suggest that the Ras protein is an upstream effector of PLC activity in phosphoinositide-specific signal transduction and that PLC-gamma activity is necessary for Ras-mediated induction of DNA synthesis.

Citing Articles

Peptides That Block RAS-p21 Protein-Induced Cell Transformation.

Pincus M, Lin B, Patel P, Gabutan E, Zohar N, Bowne W Biomedicines. 2023; 11(2).

PMID: 36831007 PMC: 9953342. DOI: 10.3390/biomedicines11020471.


Fibroblast growth factor acts upon the transcription of phospholipase C genes in human umbilical vein endothelial cells.

Lo Vasco V, Leopizzi M, Puggioni C, Della Rocca C, Businaro R Mol Cell Biochem. 2013; 388(1-2):51-9.

PMID: 24242047 DOI: 10.1007/s11010-013-1898-x.


Sprouty proteins inhibit receptor-mediated activation of phosphatidylinositol-specific phospholipase C.

Akbulut S, Reddi A, Aggarwal P, Ambardekar C, Canciani B, Kim M Mol Biol Cell. 2010; 21(19):3487-96.

PMID: 20719962 PMC: 2947483. DOI: 10.1091/mbc.E10-02-0123.


Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancer.

Bowne W, Michl J, Bluth M, Zenilman M, Pincus M Cancer Ther. 2007; 5B:331-344.

PMID: 18007958 PMC: 2078333.


Inhibition of the EGF-induced activation of phospholipase C-gamma1 by a single chain antibody fragment.

Yi K, Chung J, Lee Y, Chung H, Kim I, Suh B Oncogene. 2001; 20(55):7954-64.

PMID: 11753678 DOI: 10.1038/sj.onc.1204959.